Medication info

Emplzin Met Tablets 12.5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Dongkuk Pharmaceutical Co., Ltd.
Appearance
Biconvex oval film-coated tablet with a dark brownish purple color.
Packaging
60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/bottle
Approval status
Active

MFDS item code 202302541 · Approved 2023.08.28

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their previous doses of empagliflozin and metformin. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with a glomerular filtration rate (eGFR) below 60ml/min/1.73m2 [or creatinine clearance (CrCl) < 60 ml/min]. Because this medicine contains metformin, it must not be administered to patients with a glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 or creatinine clearance (CrCl) below 45 ml/min (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). This medicine may be administered to patients with an eGFR of 45-59 ml/ min/1.73m2 or CrCl of 45-59 ml/min only if they tolerate empagliflozin well and have no other conditions that may increase the risk of lactic acidosis. In these patients, the initial dose of metformin is 500mg or 850mg once daily, with a maximum dose of 500 mg twice daily; the permissible dose of empagliflozin is 10mg once daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Who Require Careful Administration, item 1)). If renal function declines to CrCl < 45 m/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Dongkuk Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Blood sugar control disorders
  • type 2 diabetes
  • cardiovascular diseases
View approved original text

This medication is used in combination with empagliflozin and metformin to improve blood sugar control in adults with type 2 diabetes. It is administered as an adjunct to dietary and exercise therapy and is suitable for patients with type 2 diabetes whose blood sugar is not adequately controlled. Particularly, for patients with a history of cardiovascular disease, caution is required regarding the occurrence of cardiovascular events, so it should be used safely based on expert guidelines. Overall, this medication effectively improves blood sugar levels in diabetic patients, aiding in health management.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their previous doses of empagliflozin and metformin. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take twice the dose at one time; if this occurs, skip the missed dose. No dose adjustment is necessary in patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with a glomerular filtration rate (eGFR) below 60ml/min/1.73m2 [or creatinine clearance (CrCl) < 60 ml/min]. Because this medicine contains metformin, it must not be administered to patients with a glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 or creatinine clearance (CrCl) below 45 ml/min (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). This medicine may be administered to patients with an eGFR of 45-59 ml/ min/1.73m2 or CrCl of 45-59 ml/min only if they tolerate empagliflozin well and have no other conditions that may increase the risk of lactic acidosis. In these patients, the initial dose of metformin is 500mg or 850mg once daily, with a maximum dose of 500 mg twice daily; the permissible dose of empagliflozin is 10mg once daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Who Require Careful Administration, item 1)). If renal function declines to CrCl < 45 m/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps control blood sugar and is primarily used for diabetic patients. While taking this medication, there is a possibility of developing a rare side effect known as severe lactic acidosis, so if symptoms appear, you must consult a doctor immediately. If taken with other diabetes medications, there may be a risk of hypoglycemia, so dosage adjustment may be necessary. Patients with poor kidney function or acute illnesses should not take this medication. If you are scheduled for surgery or undergoing tests that involve iodinated contrast agents, you should discontinue this medication for a certain period. Women who are pregnant or breastfeeding should not take this medication, and it is also not recommended for children or adolescents under 18 years of age. Elderly patients are at risk for decreased kidney function, so regular kidney function tests are necessary, and dosage adjustment may be needed. This medication may increase the risk of urinary and genital infections, so prompt treatment is required if symptoms of infection appear. Fluid loss may occur, so watch for signs of dehydration or low blood pressure, especially in elderly patients or those with cardiovascular diseases. During treatment, avoid alcohol consumption, and since gastrointestinal disturbances or vitamin B12 deficiency may occur, regular testing is recommended. While taking this medication, continuously monitor blood glucose levels and physical conditions, and consult medical personnel immediately if any abnormal symptoms arise.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • ketoacidosis
  • lactic acidosis
  • decreased vitamin B12 absorption
  • nausea
  • vomiting
  • diarrhea
Show 182 more
  • abdominal pain
  • loss of appetite
  • abnormal liver function tests
  • hepatitis
  • taste alteration
  • itching
  • rash
  • hives
  • erythema
  • angioedema
  • dysuria
  • thirst
  • increased serum lipids
  • increased blood creatinine
  • decreased glomerular filtration rate
  • decreased fluid volume
  • hypotension
  • dehydration
  • low blood pressure
  • decreased blood volume
  • orthostatic hypotension
  • syncope
  • chronic gastritis
  • cerebral infarction
  • soft tissue infection
  • pneumonia
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • musculoskeletal pain
  • myocardial infarction
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • intestinal bleeding
  • constipation
  • gastritis
  • dry mouth
  • gastrointestinal disturbance
  • oral discomfort
  • salivary gland pain
  • headache
  • dizziness
  • positional vertigo
  • drowsiness
  • facial paralysis
  • fatigue
  • peripheral edema
  • facial edema
  • fever
  • chills
  • strange sensation
  • edema
  • pain
  • pain at the puncture site
  • vascular stent stenosis
  • vascular stent thrombosis
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • hyperglycemia
  • hyponatremia
  • dermal cysts
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal abrasion
  • glaucoma
  • macular fibrosis
  • ocular discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • macular retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual phlegm
  • skin laceration
  • rib fracture
  • ligamentous injury syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • arteriosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • anxiety
  • depression
  • sleep disturbances
  • otalgia
  • positional vertigo
  • dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • cervical inflammation
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • otalgia
  • positional vertigo
  • vascular stent thrombosis
  • ligament injury
  • arthralgia
  • low back pain
  • urinary stones
  • acute kidney injury
  • hematuria
  • overactive bladder
  • renal mass
  • urinary retention
  • urinary pain
  • urinary abnormalities
  • cervical inflammation
  • hypercholesterolemia
  • dyslipidemia
  • vitamin D deficiency
  • nasopharyngitis
  • soft tissue infection
  • pneumonia
  • upper respiratory infection
  • nasopharyngitis
  • myasthenia
  • chest discomfort
  • chest pain
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ankle fracture
  • epicondylitis
  • facial bone fracture
  • ligament sprain
  • arthralgia
  • low back pain
  • musculoskeletal pain
  • bone loss
  • diabetic retinopathy
  • diplopia
  • cough
  • dyspnea
  • unstable angina

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and is safely stored at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy and prevent degradation of the medication.

Appearance and packaging

Appearance

Biconvex oval film-coated tablet with a dark brownish purple color.

Package unit

60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.